{"id":439812,"date":"2021-02-19T08:03:20","date_gmt":"2021-02-19T13:03:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=439812"},"modified":"2021-02-19T08:03:20","modified_gmt":"2021-02-19T13:03:20","slug":"assembly-bio-announces-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/","title":{"rendered":"Assembly Bio Announces Upcoming Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Feb.  19, 2021  (GLOBE NEWSWIRE) &#8212; Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced two upcoming investor events:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>2021 Key Objectives and Anticipated Progress Conference Call and Webcast<\/strong>, concurrent with Q4 and year end 2020 financial results at 5 p.m. ET on Thursday, February 25, 2021<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>SVB Leerink 10<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Healthcare Conference<\/strong>. John McHutchison AO, MD, Chief Executive Officer and President to participate in fireside chat at 1:40 p.m. ET on Friday, February 26, 2021<\/li>\n<\/ul>\n<p>Both live audio events will be available in the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8PMyi4C3e8_I7Vk_cQGw7eDaI2ctWD-d0iQExJqVlhV5kR4oIX0TuRRRd1NFdcf_N-6UEUFuivAK7i1v5ox9lvRnfyMBYQgtqtZX3lyQkd1zjPE1p_4EMJp5KYdg06oi\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">News &amp; Events<\/a>\u201d section of Assembly Bio\u2019s website. The archived webcasts will be available on Assembly Bio\u2019s website beginning approximately two hours after the event and will be archived and available for replay for at least 30 days after the event.<\/p>\n<p>\n        <strong>About Assembly Biosciences<\/strong><br \/>\n        <br \/>Assembly Biosciences, Inc.\u00a0is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV). The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cj96wmsj-GYXpYofy1nriyQwi23xE91mJWt_47p-jOdRC-BYPZ36qR0qfFRSiD_zzfDeYGbSIzZWglEzdnN0Ew==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">assemblybio.com<\/a>.<\/p>\n<p>\n        <strong>Investor\u00a0Contact<\/strong><br \/>\n        <br \/>Assembly Biosciences, Inc.<br \/>Lauren Glaser<br \/>Senior Vice President, Investor Relations and Corporate Affairs<br \/>(415) 521-3828<br \/><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SIefxGMpQyy4EizCjHj1FSNMSW9RJro1wjHUQMyDjgFMNa6nKpFNtW4kblSeRhE_V2koZvEQPRW441YylJasBG4bv4iVqiPzmK27UZ9muCQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lglaser@assemblybio.com<\/a><\/strong><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Sam Brown Inc.<br \/>Audra Friis<br \/>(917) 519-9577<br \/><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4mnP9SGnJmfmlM9AMFhjPLJ2sz4Y04YVJApVyRbOpjIzNJUmp9zC4Bc49DVwlykyiSa4r9V_ZZTOdy_l2e-dzPmrbi3Rd-91mC0yiAh6S1Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ASMBMedia@sambrown.com<\/a><\/strong><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/28f7b5d0-6608-4d2c-8f51-5ad6e48706af\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced two upcoming investor events: 2021 Key Objectives and Anticipated Progress Conference Call and Webcast, concurrent with Q4 and year end 2020 financial results at 5 p.m. ET on Thursday, February 25, 2021 SVB Leerink 10 th Annual Global Healthcare Conference. John McHutchison AO, MD, Chief Executive Officer and President to participate in fireside chat at 1:40 p.m. ET on Friday, February 26, 2021 Both live audio events will be available in the \u201cNews &amp; Events\u201d section of Assembly Bio\u2019s website. The archived webcasts will be available on Assembly Bio\u2019s website beginning &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Assembly Bio Announces Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-439812","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Assembly Bio Announces Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Assembly Bio Announces Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced two upcoming investor events: 2021 Key Objectives and Anticipated Progress Conference Call and Webcast, concurrent with Q4 and year end 2020 financial results at 5 p.m. ET on Thursday, February 25, 2021 SVB Leerink 10 th Annual Global Healthcare Conference. John McHutchison AO, MD, Chief Executive Officer and President to participate in fireside chat at 1:40 p.m. ET on Friday, February 26, 2021 Both live audio events will be available in the \u201cNews &amp; Events\u201d section of Assembly Bio\u2019s website. The archived webcasts will be available on Assembly Bio\u2019s website beginning &hellip; Continue reading &quot;Assembly Bio Announces Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-19T13:03:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Assembly Bio Announces Upcoming Investor Events\",\"datePublished\":\"2021-02-19T13:03:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/\"},\"wordCount\":221,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/\",\"name\":\"Assembly Bio Announces Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=\",\"datePublished\":\"2021-02-19T13:03:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/assembly-bio-announces-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Assembly Bio Announces Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Assembly Bio Announces Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Assembly Bio Announces Upcoming Investor Events - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced two upcoming investor events: 2021 Key Objectives and Anticipated Progress Conference Call and Webcast, concurrent with Q4 and year end 2020 financial results at 5 p.m. ET on Thursday, February 25, 2021 SVB Leerink 10 th Annual Global Healthcare Conference. John McHutchison AO, MD, Chief Executive Officer and President to participate in fireside chat at 1:40 p.m. ET on Friday, February 26, 2021 Both live audio events will be available in the \u201cNews &amp; Events\u201d section of Assembly Bio\u2019s website. The archived webcasts will be available on Assembly Bio\u2019s website beginning &hellip; Continue reading \"Assembly Bio Announces Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-19T13:03:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Assembly Bio Announces Upcoming Investor Events","datePublished":"2021-02-19T13:03:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/"},"wordCount":221,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/","name":"Assembly Bio Announces Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=","datePublished":"2021-02-19T13:03:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjA1NCMzOTg1MDExIzIwMjYzOTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/assembly-bio-announces-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Assembly Bio Announces Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/439812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=439812"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/439812\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=439812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=439812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=439812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}